nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—PLG—atherosclerosis	0.73	1	CbGaD
Tranexamic Acid—PLG—tunica intima—atherosclerosis	0.0221	0.282	CbGeAlD
Tranexamic Acid—PLG—vein—atherosclerosis	0.0186	0.237	CbGeAlD
Tranexamic Acid—PLG—appendage—atherosclerosis	0.0106	0.135	CbGeAlD
Tranexamic Acid—PLG—artery—atherosclerosis	0.00756	0.0965	CbGeAlD
Tranexamic Acid—PLG—endothelium—atherosclerosis	0.00639	0.0815	CbGeAlD
Tranexamic Acid—PLG—blood vessel—atherosclerosis	0.00589	0.0752	CbGeAlD
Tranexamic Acid—PLG—connective tissue—atherosclerosis	0.00302	0.0385	CbGeAlD
Tranexamic Acid—PLG—cardiovascular system—atherosclerosis	0.00263	0.0335	CbGeAlD
Tranexamic Acid—PLG—liver—atherosclerosis	0.00163	0.0207	CbGeAlD
Tranexamic Acid—Gastrointestinal symptom NOS—Niacin—atherosclerosis	0.00154	0.0239	CcSEcCtD
Tranexamic Acid—Musculoskeletal pain—Lovastatin—atherosclerosis	0.00106	0.0166	CcSEcCtD
Tranexamic Acid—Musculoskeletal pain—Pravastatin—atherosclerosis	0.0009	0.014	CcSEcCtD
Tranexamic Acid—Swelling—Simvastatin—atherosclerosis	0.00081	0.0126	CcSEcCtD
Tranexamic Acid—Atrial fibrillation—Simvastatin—atherosclerosis	0.000754	0.0117	CcSEcCtD
Tranexamic Acid—Polyuria—Niacin—atherosclerosis	0.000747	0.0116	CcSEcCtD
Tranexamic Acid—Atrial fibrillation—Niacin—atherosclerosis	0.000692	0.0108	CcSEcCtD
Tranexamic Acid—Cramp muscle—Lovastatin—atherosclerosis	0.000688	0.0107	CcSEcCtD
Tranexamic Acid—Cramp muscle—Ezetimibe—atherosclerosis	0.000675	0.0105	CcSEcCtD
Tranexamic Acid—Sinusitis—Rosuvastatin—atherosclerosis	0.000652	0.0101	CcSEcCtD
Tranexamic Acid—Migraine—Niacin—atherosclerosis	0.000646	0.0101	CcSEcCtD
Tranexamic Acid—Cramp muscle—Simvastatin—atherosclerosis	0.000643	0.01	CcSEcCtD
Tranexamic Acid—Abdominal discomfort—Lovastatin—atherosclerosis	0.000633	0.00986	CcSEcCtD
Tranexamic Acid—Abdominal discomfort—Simvastatin—atherosclerosis	0.000592	0.00922	CcSEcCtD
Tranexamic Acid—Cramp muscle—Pravastatin—atherosclerosis	0.000582	0.00906	CcSEcCtD
Tranexamic Acid—Arrhythmia—Rosuvastatin—atherosclerosis	0.000557	0.00867	CcSEcCtD
Tranexamic Acid—Angina pectoris—Niacin—atherosclerosis	0.000552	0.0086	CcSEcCtD
Tranexamic Acid—Sinusitis—Lovastatin—atherosclerosis	0.000552	0.0086	CcSEcCtD
Tranexamic Acid—Angina pectoris—Pravastatin—atherosclerosis	0.000544	0.00847	CcSEcCtD
Tranexamic Acid—Sinusitis—Ezetimibe—atherosclerosis	0.000542	0.00843	CcSEcCtD
Tranexamic Acid—Sinusitis—Simvastatin—atherosclerosis	0.000516	0.00804	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000491	0.00764	CcSEcCtD
Tranexamic Acid—Flushing—Lovastatin—atherosclerosis	0.00049	0.00764	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Pravastatin—atherosclerosis	0.000488	0.0076	CcSEcCtD
Tranexamic Acid—Flushing—Ezetimibe—atherosclerosis	0.000481	0.00749	CcSEcCtD
Tranexamic Acid—Angiopathy—Ezetimibe—atherosclerosis	0.00047	0.00732	CcSEcCtD
Tranexamic Acid—Immune system disorder—Ezetimibe—atherosclerosis	0.000468	0.00729	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000467	0.00727	CcSEcCtD
Tranexamic Acid—Sinusitis—Pravastatin—atherosclerosis	0.000467	0.00727	CcSEcCtD
Tranexamic Acid—Myalgia—Rosuvastatin—atherosclerosis	0.000462	0.0072	CcSEcCtD
Tranexamic Acid—Arthralgia—Rosuvastatin—atherosclerosis	0.000462	0.0072	CcSEcCtD
Tranexamic Acid—Flushing—Simvastatin—atherosclerosis	0.000459	0.00714	CcSEcCtD
Tranexamic Acid—Haemoglobin—Niacin—atherosclerosis	0.000456	0.0071	CcSEcCtD
Tranexamic Acid—Haemorrhage—Niacin—atherosclerosis	0.000454	0.00707	CcSEcCtD
Tranexamic Acid—Back pain—Lovastatin—atherosclerosis	0.000445	0.00693	CcSEcCtD
Tranexamic Acid—Muscle spasms—Lovastatin—atherosclerosis	0.000442	0.00689	CcSEcCtD
Tranexamic Acid—Visual impairment—Niacin—atherosclerosis	0.000437	0.00681	CcSEcCtD
Tranexamic Acid—Back pain—Ezetimibe—atherosclerosis	0.000436	0.0068	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000434	0.00677	CcSEcCtD
Tranexamic Acid—Muscle spasms—Ezetimibe—atherosclerosis	0.000434	0.00675	CcSEcCtD
Tranexamic Acid—Visual impairment—Pravastatin—atherosclerosis	0.000431	0.00671	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Lovastatin—atherosclerosis	0.000427	0.00665	CcSEcCtD
Tranexamic Acid—Eye disorder—Niacin—atherosclerosis	0.000424	0.0066	CcSEcCtD
Tranexamic Acid—Flushing—Niacin—atherosclerosis	0.000421	0.00656	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000419	0.00652	CcSEcCtD
Tranexamic Acid—Anaemia—Ezetimibe—atherosclerosis	0.000417	0.00649	CcSEcCtD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—CCL2—atherosclerosis	0.000415	0.00327	CbGpPWpGaD
Tranexamic Acid—Malaise—Lovastatin—atherosclerosis	0.000415	0.00646	CcSEcCtD
Tranexamic Acid—PLG—Complement and Coagulation Cascades—F2—atherosclerosis	0.000415	0.00326	CbGpPWpGaD
Tranexamic Acid—Cardiac disorder—Pravastatin—atherosclerosis	0.000415	0.00646	CcSEcCtD
Tranexamic Acid—Flushing—Pravastatin—atherosclerosis	0.000415	0.00646	CcSEcCtD
Tranexamic Acid—Muscle spasms—Simvastatin—atherosclerosis	0.000414	0.00644	CcSEcCtD
Tranexamic Acid—Angiopathy—Niacin—atherosclerosis	0.000412	0.00641	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—CRP—atherosclerosis	0.000411	0.00323	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP3—atherosclerosis	0.000409	0.00322	CbGpPWpGaD
Tranexamic Acid—Malaise—Ezetimibe—atherosclerosis	0.000407	0.00634	CcSEcCtD
Tranexamic Acid—Arrhythmia—Niacin—atherosclerosis	0.000405	0.00631	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000404	0.00629	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MMP2—atherosclerosis	0.000401	0.00316	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Simvastatin—atherosclerosis	0.000399	0.00622	CcSEcCtD
Tranexamic Acid—Arrhythmia—Pravastatin—atherosclerosis	0.000399	0.00622	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—APOB—atherosclerosis	0.000399	0.00314	CbGpPWpGaD
Tranexamic Acid—Anaemia—Simvastatin—atherosclerosis	0.000398	0.00619	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—APOA1—atherosclerosis	0.000397	0.00313	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SELP—atherosclerosis	0.000394	0.0031	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—F5—atherosclerosis	0.000394	0.0031	CbGpPWpGaD
Tranexamic Acid—Myalgia—Lovastatin—atherosclerosis	0.000392	0.0061	CcSEcCtD
Tranexamic Acid—Arthralgia—Lovastatin—atherosclerosis	0.000392	0.0061	CcSEcCtD
Tranexamic Acid—Chest pain—Lovastatin—atherosclerosis	0.000392	0.0061	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—CD36—atherosclerosis	0.000391	0.00307	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Rosuvastatin—atherosclerosis	0.00039	0.00607	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SOD2—atherosclerosis	0.00039	0.00307	CbGpPWpGaD
Tranexamic Acid—Malaise—Simvastatin—atherosclerosis	0.000388	0.00604	CcSEcCtD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—SERPINE1—atherosclerosis	0.000388	0.00305	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—ALB—atherosclerosis	0.000387	0.00305	CbGpPWpGaD
Tranexamic Acid—Discomfort—Lovastatin—atherosclerosis	0.000387	0.00603	CcSEcCtD
Tranexamic Acid—Arthralgia—Ezetimibe—atherosclerosis	0.000384	0.00598	CcSEcCtD
Tranexamic Acid—Myalgia—Ezetimibe—atherosclerosis	0.000384	0.00598	CcSEcCtD
Tranexamic Acid—Chest pain—Ezetimibe—atherosclerosis	0.000384	0.00598	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—PRKCG—atherosclerosis	0.000381	0.003	CbGpPWpGaD
Tranexamic Acid—Muscle spasms—Niacin—atherosclerosis	0.00038	0.00591	CcSEcCtD
Tranexamic Acid—Discomfort—Ezetimibe—atherosclerosis	0.000379	0.00591	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—F2—atherosclerosis	0.000379	0.00298	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—ICAM1—atherosclerosis	0.000378	0.00297	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—CLU—atherosclerosis	0.000376	0.00296	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—NOS3—atherosclerosis	0.000376	0.00296	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Lovastatin—atherosclerosis	0.000375	0.00585	CcSEcCtD
Tranexamic Acid—Muscle spasms—Pravastatin—atherosclerosis	0.000374	0.00582	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—CD36—atherosclerosis	0.000372	0.00293	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—GPX1—atherosclerosis	0.000372	0.00293	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000368	0.00573	CcSEcCtD
Tranexamic Acid—Chest pain—Simvastatin—atherosclerosis	0.000366	0.0057	CcSEcCtD
Tranexamic Acid—Arthralgia—Simvastatin—atherosclerosis	0.000366	0.0057	CcSEcCtD
Tranexamic Acid—Myalgia—Simvastatin—atherosclerosis	0.000366	0.0057	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000365	0.00568	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000362	0.00564	CcSEcCtD
Tranexamic Acid—Discomfort—Simvastatin—atherosclerosis	0.000362	0.00564	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Ezetimibe—atherosclerosis	0.000361	0.00562	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Pravastatin—atherosclerosis	0.000361	0.00562	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—PDGFB—atherosclerosis	0.00036	0.00284	CbGpPWpGaD
Tranexamic Acid—Anaemia—Pravastatin—atherosclerosis	0.000359	0.0056	CcSEcCtD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—SPP1—atherosclerosis	0.000358	0.00281	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IFNG—atherosclerosis	0.000353	0.00278	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Simvastatin—atherosclerosis	0.000351	0.00547	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP8—atherosclerosis	0.000351	0.00276	CbGpPWpGaD
Tranexamic Acid—Malaise—Pravastatin—atherosclerosis	0.000351	0.00546	CcSEcCtD
Tranexamic Acid—Abdominal pain—Rosuvastatin—atherosclerosis	0.00035	0.00545	CcSEcCtD
Tranexamic Acid—PLG—Orphan transporters—APOB—atherosclerosis	0.000349	0.00275	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Niacin—atherosclerosis	0.000347	0.00541	CcSEcCtD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—atherosclerosis	0.000347	0.00273	CbGpPWpGaD
Tranexamic Acid—PLG—Complement and Coagulation Cascades—SERPINE1—atherosclerosis	0.000345	0.00272	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—INS—atherosclerosis	0.000343	0.0027	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—PDGFB—atherosclerosis	0.000343	0.0027	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—MTHFR—atherosclerosis	0.000343	0.0027	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000342	0.00533	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—APOA1—atherosclerosis	0.000341	0.00268	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—CCL2—atherosclerosis	0.000338	0.00266	CbGpPWpGaD
Tranexamic Acid—Myalgia—Niacin—atherosclerosis	0.000336	0.00524	CcSEcCtD
Tranexamic Acid—Arthralgia—Niacin—atherosclerosis	0.000336	0.00524	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000335	0.00522	CcSEcCtD
Tranexamic Acid—Dyspnoea—Lovastatin—atherosclerosis	0.000335	0.00521	CcSEcCtD
Tranexamic Acid—PLG—amb2 Integrin signaling—TNF—atherosclerosis	0.000332	0.00261	CbGpPWpGaD
Tranexamic Acid—Arthralgia—Pravastatin—atherosclerosis	0.000331	0.00516	CcSEcCtD
Tranexamic Acid—Chest pain—Pravastatin—atherosclerosis	0.000331	0.00516	CcSEcCtD
Tranexamic Acid—Myalgia—Pravastatin—atherosclerosis	0.000331	0.00516	CcSEcCtD
Tranexamic Acid—Dyspepsia—Lovastatin—atherosclerosis	0.00033	0.00515	CcSEcCtD
Tranexamic Acid—Dyspnoea—Ezetimibe—atherosclerosis	0.000328	0.00511	CcSEcCtD
Tranexamic Acid—Discomfort—Pravastatin—atherosclerosis	0.000327	0.0051	CcSEcCtD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP1—atherosclerosis	0.000327	0.00257	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—CRP—atherosclerosis	0.000326	0.00257	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000326	0.00508	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—APOA1—atherosclerosis	0.000325	0.00255	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Ezetimibe—atherosclerosis	0.000324	0.00505	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—OLR1—atherosclerosis	0.000324	0.00255	CbGpPWpGaD
Tranexamic Acid—Fatigue—Lovastatin—atherosclerosis	0.000324	0.00504	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Niacin—atherosclerosis	0.000322	0.00502	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00032	0.00498	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000318	0.00495	CcSEcCtD
Tranexamic Acid—Asthenia—Rosuvastatin—atherosclerosis	0.000318	0.00495	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Pravastatin—atherosclerosis	0.000317	0.00494	CcSEcCtD
Tranexamic Acid—Fatigue—Ezetimibe—atherosclerosis	0.000317	0.00494	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—BGN—atherosclerosis	0.000316	0.00249	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—APOA1—atherosclerosis	0.000316	0.00248	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—SERPINE1—atherosclerosis	0.000315	0.00248	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL1B—atherosclerosis	0.000315	0.00248	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—ALB—atherosclerosis	0.000315	0.00248	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Simvastatin—atherosclerosis	0.000313	0.00488	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Lovastatin—atherosclerosis	0.000309	0.00482	CcSEcCtD
Tranexamic Acid—Dyspepsia—Simvastatin—atherosclerosis	0.000309	0.00481	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000307	0.00478	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Ezetimibe—atherosclerosis	0.000303	0.00473	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000303	0.00472	CcSEcCtD
Tranexamic Acid—Diarrhoea—Rosuvastatin—atherosclerosis	0.000303	0.00472	CcSEcCtD
Tranexamic Acid—Fatigue—Simvastatin—atherosclerosis	0.000303	0.00471	CcSEcCtD
Tranexamic Acid—Hypotension—Niacin—atherosclerosis	0.000301	0.00469	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—F2—atherosclerosis	0.000301	0.00237	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000301	0.00469	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—ICAM1—atherosclerosis	0.0003	0.00236	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VWF—atherosclerosis	0.000299	0.00235	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—NFKB1—atherosclerosis	0.000299	0.00235	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PLAT—atherosclerosis	0.000297	0.00234	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Lovastatin—atherosclerosis	0.000297	0.00462	CcSEcCtD
Tranexamic Acid—PLG—Orphan transporters—PPARA—atherosclerosis	0.000294	0.00232	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—NFKB1—atherosclerosis	0.000294	0.00231	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000294	0.00457	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK8—atherosclerosis	0.000293	0.00231	CbGpPWpGaD
Tranexamic Acid—Dizziness—Rosuvastatin—atherosclerosis	0.000293	0.00456	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000292	0.0023	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Ezetimibe—atherosclerosis	0.000291	0.00453	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Simvastatin—atherosclerosis	0.000289	0.00451	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000289	0.0045	CcSEcCtD
Tranexamic Acid—Dyspnoea—Niacin—atherosclerosis	0.000287	0.00448	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—IFNG—atherosclerosis	0.000287	0.00226	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000287	0.00447	CcSEcCtD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—atherosclerosis	0.000286	0.00225	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—IGF1—atherosclerosis	0.000285	0.00224	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Niacin—atherosclerosis	0.000284	0.00442	CcSEcCtD
Tranexamic Acid—Dyspnoea—Pravastatin—atherosclerosis	0.000283	0.00441	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00028	0.00221	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Pravastatin—atherosclerosis	0.000279	0.00435	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Niacin—atherosclerosis	0.000278	0.00433	CcSEcCtD
Tranexamic Acid—Abdominal pain—Simvastatin—atherosclerosis	0.000278	0.00432	CcSEcCtD
Tranexamic Acid—Headache—Rosuvastatin—atherosclerosis	0.000277	0.00432	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Lovastatin—atherosclerosis	0.000277	0.00431	CcSEcCtD
Tranexamic Acid—Fatigue—Pravastatin—atherosclerosis	0.000274	0.00426	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—INS—atherosclerosis	0.000273	0.00215	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—IGF1—atherosclerosis	0.000271	0.00214	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Ezetimibe—atherosclerosis	0.000271	0.00422	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—SERPINE1—atherosclerosis	0.00027	0.00213	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—ALB—atherosclerosis	0.00027	0.00212	CbGpPWpGaD
Tranexamic Acid—Asthenia—Lovastatin—atherosclerosis	0.000269	0.00419	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—CCL2—atherosclerosis	0.000268	0.00211	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—IL6—atherosclerosis	0.000268	0.00211	CbGpPWpGaD
Tranexamic Acid—Asthenia—Ezetimibe—atherosclerosis	0.000264	0.00411	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Niacin—atherosclerosis	0.000264	0.00411	CcSEcCtD
Tranexamic Acid—Nausea—Rosuvastatin—atherosclerosis	0.000263	0.0041	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Pravastatin—atherosclerosis	0.000262	0.00407	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00026	0.00404	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Simvastatin—atherosclerosis	0.000259	0.00403	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—SERPINE1—atherosclerosis	0.000258	0.00203	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—ALB—atherosclerosis	0.000257	0.00202	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Lovastatin—atherosclerosis	0.000257	0.004	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK3—atherosclerosis	0.000256	0.00202	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL1B—atherosclerosis	0.000256	0.00202	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SERPINC1—atherosclerosis	0.000256	0.00201	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Niacin—atherosclerosis	0.000255	0.00397	CcSEcCtD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP2—atherosclerosis	0.000253	0.00199	CbGpPWpGaD
Tranexamic Acid—Asthenia—Simvastatin—atherosclerosis	0.000252	0.00392	CcSEcCtD
Tranexamic Acid—Diarrhoea—Ezetimibe—atherosclerosis	0.000252	0.00392	CcSEcCtD
Tranexamic Acid—Abdominal pain—Pravastatin—atherosclerosis	0.000251	0.00391	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.000251	0.00197	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—ALB—atherosclerosis	0.00025	0.00197	CbGpPWpGaD
Tranexamic Acid—Dizziness—Lovastatin—atherosclerosis	0.000248	0.00387	CcSEcCtD
Tranexamic Acid—Dizziness—Ezetimibe—atherosclerosis	0.000243	0.00379	CcSEcCtD
Tranexamic Acid—Diarrhoea—Simvastatin—atherosclerosis	0.00024	0.00374	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—NFKB1—atherosclerosis	0.000239	0.00188	CbGpPWpGaD
Tranexamic Acid—Vomiting—Lovastatin—atherosclerosis	0.000239	0.00372	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Niacin—atherosclerosis	0.000238	0.0037	CcSEcCtD
Tranexamic Acid—Headache—Lovastatin—atherosclerosis	0.000235	0.00366	CcSEcCtD
Tranexamic Acid—Vomiting—Ezetimibe—atherosclerosis	0.000234	0.00365	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Pravastatin—atherosclerosis	0.000234	0.00364	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—TNF—atherosclerosis	0.000232	0.00183	CbGpPWpGaD
Tranexamic Acid—Dizziness—Simvastatin—atherosclerosis	0.000232	0.00362	CcSEcCtD
Tranexamic Acid—Asthenia—Niacin—atherosclerosis	0.000231	0.0036	CcSEcCtD
Tranexamic Acid—Headache—Ezetimibe—atherosclerosis	0.000231	0.00359	CcSEcCtD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—TNF—atherosclerosis	0.000229	0.0018	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IFNG—atherosclerosis	0.000228	0.0018	CbGpPWpGaD
Tranexamic Acid—Asthenia—Pravastatin—atherosclerosis	0.000228	0.00355	CcSEcCtD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—MAPK8—atherosclerosis	0.000227	0.00178	CbGpPWpGaD
Tranexamic Acid—Vomiting—Simvastatin—atherosclerosis	0.000223	0.00348	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—KNG1—atherosclerosis	0.000223	0.00176	CbGpPWpGaD
Tranexamic Acid—Nausea—Lovastatin—atherosclerosis	0.000223	0.00347	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000221	0.00174	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Niacin—atherosclerosis	0.000221	0.00344	CcSEcCtD
Tranexamic Acid—Headache—Simvastatin—atherosclerosis	0.00022	0.00343	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—PTGS2—atherosclerosis	0.000219	0.00172	CbGpPWpGaD
Tranexamic Acid—Nausea—Ezetimibe—atherosclerosis	0.000219	0.00341	CcSEcCtD
Tranexamic Acid—Diarrhoea—Pravastatin—atherosclerosis	0.000217	0.00338	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—F3—atherosclerosis	0.000214	0.00169	CbGpPWpGaD
Tranexamic Acid—Dizziness—Niacin—atherosclerosis	0.000213	0.00332	CcSEcCtD
Tranexamic Acid—Dizziness—Pravastatin—atherosclerosis	0.00021	0.00327	CcSEcCtD
Tranexamic Acid—Nausea—Simvastatin—atherosclerosis	0.000209	0.00325	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SOD1—atherosclerosis	0.000207	0.00163	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PRKCG—atherosclerosis	0.000207	0.00163	CbGpPWpGaD
Tranexamic Acid—Vomiting—Niacin—atherosclerosis	0.000205	0.00319	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL1B—atherosclerosis	0.000204	0.0016	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SELP—atherosclerosis	0.000203	0.0016	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—F5—atherosclerosis	0.000203	0.0016	CbGpPWpGaD
Tranexamic Acid—Headache—Niacin—atherosclerosis	0.000202	0.00315	CcSEcCtD
Tranexamic Acid—Vomiting—Pravastatin—atherosclerosis	0.000202	0.00314	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—SPP1—atherosclerosis	0.000202	0.00159	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000201	0.00158	CbGpPWpGaD
Tranexamic Acid—Headache—Pravastatin—atherosclerosis	0.000199	0.0031	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IGF2—atherosclerosis	0.000197	0.00155	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CLU—atherosclerosis	0.000194	0.00153	CbGpPWpGaD
Tranexamic Acid—Nausea—Niacin—atherosclerosis	0.000191	0.00298	CcSEcCtD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP9—atherosclerosis	0.00019	0.0015	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.00019	0.00149	CbGpPWpGaD
Tranexamic Acid—Nausea—Pravastatin—atherosclerosis	0.000189	0.00294	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PDGFB—atherosclerosis	0.000187	0.00147	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—VEGFA—atherosclerosis	0.000186	0.00146	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—TNF—atherosclerosis	0.000186	0.00146	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL6—atherosclerosis	0.000184	0.00145	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—VCAM1—atherosclerosis	0.000183	0.00144	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—THBD—atherosclerosis	0.000182	0.00143	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000181	0.00142	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PRKCG—atherosclerosis	0.000177	0.0014	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—atherosclerosis	0.000177	0.00139	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—PLA2G7—atherosclerosis	0.000176	0.00139	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000174	0.00137	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—CD36—atherosclerosis	0.000173	0.00136	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—AKT1—atherosclerosis	0.000173	0.00136	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SELE—atherosclerosis	0.000173	0.00136	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP3—atherosclerosis	0.000171	0.00135	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—TGFB1—atherosclerosis	0.000171	0.00134	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000167	0.00131	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—TGFB1—atherosclerosis	0.000163	0.00128	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00016	0.00126	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PDGFB—atherosclerosis	0.00016	0.00126	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VWF—atherosclerosis	0.000154	0.00121	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—APOA1—atherosclerosis	0.000151	0.00119	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL6—atherosclerosis	0.00015	0.00118	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—SPP1—atherosclerosis	0.00015	0.00118	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—TNF—atherosclerosis	0.000148	0.00116	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—F7—atherosclerosis	0.000147	0.00116	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—F2—atherosclerosis	0.000144	0.00113	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—HSPD1—atherosclerosis	0.000143	0.00113	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—PDGFB—atherosclerosis	0.000139	0.00109	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CG—atherosclerosis	0.000138	0.00109	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP1—atherosclerosis	0.000137	0.00108	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—AKT1—atherosclerosis	0.000134	0.00105	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PLAT—atherosclerosis	0.000131	0.00103	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000129	0.00101	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000126	0.000995	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IGF1—atherosclerosis	0.000126	0.000994	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ICAM1—atherosclerosis	0.000125	0.00098	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	0.00012	0.000944	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ALB—atherosclerosis	0.00012	0.000942	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL6—atherosclerosis	0.000119	0.000938	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—F7—atherosclerosis	0.000116	0.00091	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—KNG1—atherosclerosis	0.000115	0.000905	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000115	0.000902	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PLAUR—atherosclerosis	0.000114	0.000897	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000113	0.000892	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SOD1—atherosclerosis	0.000107	0.00084	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP2—atherosclerosis	0.000106	0.000835	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—SERPINE1—atherosclerosis	0.000104	0.000819	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000103	0.000811	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—GHRL—atherosclerosis	0.000103	0.000811	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HRH1—atherosclerosis	0.000102	0.000803	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IGF2—atherosclerosis	0.000101	0.000798	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—ACE—atherosclerosis	9.98e-05	0.000785	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	9.92e-05	0.000781	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—APOB—atherosclerosis	9.85e-05	0.000775	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—STAT3—atherosclerosis	9.54e-05	0.000751	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PRKCG—atherosclerosis	9.14e-05	0.000719	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK3—atherosclerosis	9.12e-05	0.000718	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—PLAUR—atherosclerosis	8.96e-05	0.000706	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CD36—atherosclerosis	8.93e-05	0.000703	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—HMOX1—atherosclerosis	8.9e-05	0.0007	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—APOB—atherosclerosis	8.52e-05	0.000671	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	8.25e-05	0.000649	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PDGFB—atherosclerosis	8.24e-05	0.000648	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MMP1—atherosclerosis	8.14e-05	0.000641	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APOA4—atherosclerosis	8.01e-05	0.00063	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—IGF2—atherosclerosis	7.98e-05	0.000628	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP9—atherosclerosis	7.97e-05	0.000627	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CAV1—atherosclerosis	7.81e-05	0.000614	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	7.81e-05	0.000614	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—APOA1—atherosclerosis	7.79e-05	0.000613	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	7.57e-05	0.000596	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—F2—atherosclerosis	7.43e-05	0.000585	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCL4—atherosclerosis	7.38e-05	0.000581	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—CETP—atherosclerosis	7.34e-05	0.000578	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—NOS2—atherosclerosis	7.34e-05	0.000578	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.19e-05	0.000566	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CG—atherosclerosis	7.11e-05	0.00056	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APOA2—atherosclerosis	6.89e-05	0.000542	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.74e-05	0.000531	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—IL6—atherosclerosis	6.67e-05	0.000525	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—UTS2—atherosclerosis	6.57e-05	0.000517	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—TGFB1—atherosclerosis	6.57e-05	0.000517	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IGF1—atherosclerosis	6.51e-05	0.000512	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—PLAT—atherosclerosis	6.47e-05	0.000509	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MMP1—atherosclerosis	6.41e-05	0.000504	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—AGT—atherosclerosis	6.33e-05	0.000498	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CX3CR1—atherosclerosis	6.3e-05	0.000496	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CASR—atherosclerosis	6.3e-05	0.000496	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—LEP—atherosclerosis	6.2e-05	0.000488	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SERPINE1—atherosclerosis	6.18e-05	0.000487	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CX3CL1—atherosclerosis	6.18e-05	0.000486	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ALB—atherosclerosis	6.17e-05	0.000486	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—AKT1—atherosclerosis	6.15e-05	0.000484	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—ALB—atherosclerosis	6e-05	0.000472	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—NOS3—atherosclerosis	5.9e-05	0.000465	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CNR2—atherosclerosis	5.86e-05	0.000461	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—F2—atherosclerosis	5.85e-05	0.00046	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—PLG—atherosclerosis	5.5e-05	0.000433	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ALB—atherosclerosis	5.34e-05	0.00042	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—INS—atherosclerosis	5.3e-05	0.000417	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	5.26e-05	0.000414	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VWF—atherosclerosis	5.22e-05	0.000411	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CCL2—atherosclerosis	5.21e-05	0.00041	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APOC3—atherosclerosis	5.19e-05	0.000409	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LDLR—atherosclerosis	5.16e-05	0.000406	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—IGF1—atherosclerosis	5.12e-05	0.000403	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.08e-05	0.0004	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCL3—atherosclerosis	5.04e-05	0.000397	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MMP2—atherosclerosis	4.96e-05	0.00039	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—APOB—atherosclerosis	4.86e-05	0.000383	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NCF1—atherosclerosis	4.83e-05	0.00038	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCR2—atherosclerosis	4.56e-05	0.000359	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EDNRA—atherosclerosis	4.56e-05	0.000359	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CYBA—atherosclerosis	4.54e-05	0.000357	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GHRL—atherosclerosis	4.44e-05	0.00035	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PARP1—atherosclerosis	4.44e-05	0.00035	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PLAT—atherosclerosis	4.44e-05	0.00035	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VEGFA—atherosclerosis	4.25e-05	0.000335	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CXCL8—atherosclerosis	4.12e-05	0.000324	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.1e-05	0.000323	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MAPK3—atherosclerosis	4.02e-05	0.000317	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TGFB1—atherosclerosis	3.9e-05	0.000307	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KNG1—atherosclerosis	3.9e-05	0.000307	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AGTR1—atherosclerosis	3.87e-05	0.000305	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.85e-05	0.000303	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SOCS3—atherosclerosis	3.58e-05	0.000281	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP3—atherosclerosis	3.45e-05	0.000272	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IGF2—atherosclerosis	3.44e-05	0.000271	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APOB—atherosclerosis	3.34e-05	0.000263	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EDN1—atherosclerosis	3.28e-05	0.000259	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCL5—atherosclerosis	3.26e-05	0.000257	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LPL—atherosclerosis	3.19e-05	0.000251	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PRKCG—atherosclerosis	3.1e-05	0.000244	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ALB—atherosclerosis	3.05e-05	0.00024	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SPP1—atherosclerosis	3.02e-05	0.000238	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PDGFB—atherosclerosis	2.79e-05	0.00022	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AGT—atherosclerosis	2.73e-05	0.000215	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT1—atherosclerosis	2.71e-05	0.000214	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LEP—atherosclerosis	2.67e-05	0.00021	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APOE—atherosclerosis	2.67e-05	0.00021	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CAV1—atherosclerosis	2.65e-05	0.000208	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APOA1—atherosclerosis	2.64e-05	0.000208	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ESR1—atherosclerosis	2.55e-05	0.000201	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—F2—atherosclerosis	2.52e-05	0.000198	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CG—atherosclerosis	2.41e-05	0.00019	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—INS—atherosclerosis	2.28e-05	0.00018	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCL2—atherosclerosis	2.25e-05	0.000177	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IGF1—atherosclerosis	2.21e-05	0.000174	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SERPINE1—atherosclerosis	2.1e-05	0.000165	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOS3—atherosclerosis	2e-05	0.000158	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL8—atherosclerosis	1.78e-05	0.00014	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP9—atherosclerosis	1.61e-05	0.000126	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NFKB1—atherosclerosis	1.59e-05	0.000125	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK8—atherosclerosis	1.56e-05	0.000123	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—atherosclerosis	1.44e-05	0.000113	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STAT3—atherosclerosis	1.43e-05	0.000112	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK3—atherosclerosis	1.36e-05	0.000107	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TGFB1—atherosclerosis	1.32e-05	0.000104	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6—atherosclerosis	9.97e-06	7.85e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT1—atherosclerosis	9.2e-06	7.24e-05	CbGpPWpGaD
